ArticleLancet regional health. Americas2026

Measuring the health benefits and costs of antimicrobial-resistant gonorrhea surveillance in the United States: an agent-based model and cost-effectiveness analysis.

Marcy S Ekanayake-Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.